Patent · US Active

Anti-alphavbeta1 integrin compounds and methods

US10131658B2 · kind B2 · utility

14Cited by
14References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2016
Grant dateNov 20, 2018
Priority date
Expiry dateMar 29, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T29/49826
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein, inter alia, are methods and compositions for inhibiting αvβ1 integrin and for treating fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.